Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy

✍ Scribed by Sunaga, Noriaki; Tomizawa, Yoshio; Yanagitani, Noriko; Iijima, Hironobu; Kaira, Kyoichi; Shimizu, Kimihiro; Tanaka, Shigebumi; Suga, Tatsuo; Hisada, Takeshi; Ishizuka, Tamotsu; Saito, Ryusei; Dobashi, Kunio; Mori, Masatomo

• Book ID: 119319597
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 177 KB
• Volume: 56
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2007.01.025